Assessing the appropriate dose and efficacy of bovine lactoferrin to correct iron deficiency anaemia in non pregnant women: A community-based randomized controlled trial in Mirpur, Dhaka

• Register: ANZCTR
• Last refreshed on: 23 October 2017
• Main ID: ACTRN12617001455358
• Date of registration: 13/10/2017
• Prospective Registration: Yes
• Primary sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)
• Public title: Assessing the appropriate dose and efficacy of bovine lactoferrin to correct iron deficiency anaemia in non pregnant women: A community-based randomized controlled trial in Mirpur, Dhaka
• Scientific title: Assessing the appropriate dose and efficacy of bovine lactoferrin to correct iron deficiency anaemia in non pregnant women: A community-based randomized controlled trial in Mirpur, Dhaka
• Date of first enrolment: 1/11/2017
• Target sample size: 556
• Recruitment status: Not yet recruiting
• URL: http://www.anzctr.org.au/ACTRN12617001455358.aspx
• Study type: Interventional
• Study design: Randomised controlled trial Parallel
• Phase: Not Applicable

Health Condition(s) or Problem(s) studied

Iron Deficiency Anemia

Intervention(s)

We will conduct a non-inferiority, double blind, individually randomized controlled trial in non-pregnant women of reproductive age with iron deficiency anaemia (haemoglobin <120 g/L & serum ferritin <30 µg/L) to assess the haemoglobin and iron status in response to i) 200mg oral bovine lactoferrin, ii) 400mg of oral bovine lactoferrin iii) standard oral iron supplements (60mg elemental iron). The intervention (each capsule once daily) will be continued for 3 months. Study personnel (field implementer and study physicians) will have monthly contacts with the enrolled women for monitoring compliance to intervention.